Ocugen (OCGN) Change in Cash (2014 - 2026)
Ocugen (OCGN) posted Change in Cash of $13.3 million for Q1 2026, up 194.96% on a QoQ basis from -$14.0 million in Q4 2025, and up 164.15% year-over-year from $5.0 million in Q1 2025.
Ocugen (OCGN) Change in Cash (2014 - 2026) Analysis & Trends
Ocugen's Change in Cash history runs 13 years deep, the most recent figure standing at $13.3 million for Q1 2026.
- Quarterly Change in Cash rose 164.15% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.9 million (down 150.59% YoY) and the FY2025 annual result came in at -$39.9 million, down 306.28% from the prior year.
- Change in Cash was $13.3 million for Q1 2026 at Ocugen, up from -$14.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $34.8 million in Q1 2022 and bottomed at -$24.0 million in Q4 2022.
- A 5-year average of -$3.7 million and a median of -$10.8 million in 2025 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 241.42% in 2024, while the deepest fall reached 547.43% in 2024.
- Ocugen's Change in Cash stood at -$24.0 million in 2022, then surged by 41.7% to -$14.0 million in 2023, then jumped by 241.42% to $19.8 million in 2024, then tumbled by 170.59% to -$14.0 million in 2025, then soared by 194.96% to $13.3 million in 2026.
- Business Quant data shows OCGN's Change in Cash at $13.3 million in Q1 2026, -$14.0 million in Q4 2025, and $5.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 13.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.29 Mn |
| Dec 31, 2025 | -13.99 Mn |
| Sep 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | -10.79 Mn |
| Mar 31, 2025 | -20.71 Mn |
| Dec 31, 2024 | 19.82 Mn |
| Sep 30, 2024 | 23.00 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Mar 31, 2024 | -13.09 Mn |
| Dec 31, 2023 | -14.02 Mn |
| Sep 30, 2023 | -17.10 Mn |
| Jun 30, 2023 | 2.32 Mn |
| Mar 31, 2023 | -9.30 Mn |
| Dec 31, 2022 | -24.04 Mn |
| Sep 30, 2022 | -13.40 Mn |
| Jun 30, 2022 | -14.92 Mn |
| Mar 31, 2022 | 34.81 Mn |
| Dec 31, 2021 | -12.39 Mn |
| Sep 30, 2021 | -8.29 Mn |
| Jun 30, 2021 | 70.85 Mn |